PUBLICATION
Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency
- Authors
- Wang, J., Yan, H.B., Zhang, Q., Liu, W.Y., Jiang, Y.H., Peng, G., Wu, F.Z., Liu, X., Yang, P.Y., Liu, F.
- ID
- ZDB-PUB-210723-2
- Date
- 2021
- Source
- Oncogene 40(36): 5468-5481 (Journal)
- Registered Authors
- Peng, Gang
- Keywords
- none
- MeSH Terms
-
- Animals
- Antigens, CD*
- Cadherins*
- Humans
- Mice
- PubMed
- 34290402 Full text @ Oncogene
Citation
Wang, J., Yan, H.B., Zhang, Q., Liu, W.Y., Jiang, Y.H., Peng, G., Wu, F.Z., Liu, X., Yang, P.Y., Liu, F. (2021) Enhancement of E-cadherin expression and processing and driving of cancer cell metastasis by ARID1A deficiency. Oncogene. 40(36):5468-5481.
Abstract
The ARID1A gene, which encodes a subunit of the SWI/SNF chromatin remodeling complex, has been found to be frequently mutated in many human cancer types. However, the function and mechanism of ARID1A in cancer metastasis are still unclear. Here, we show that knockdown of ARID1A increases the ability of breast cancer cells to proliferate, migrate, invade, and metastasize in vivo. The ARID1A-related SWI/SNF complex binds to the second exon of CDH1 and negatively modulates the expression of E-cadherin/CDH1 by recruiting the transcriptional repressor ZEB2 to the CDH1 promoter and excluding the presence of RNA polymerase II. The silencing of CDH1 attenuated the migration, invasion, and metastasis of breast cancer cells in which ARID1A was silenced. ARID1A depletion increased the intracellular enzymatic processing of E-cadherin and the production of C-terminal fragment 2 (CTF2) of E-cadherin, which stabilized β-catenin by competing for binding to the phosphorylation and degradation complex of β-catenin. The matrix metalloproteinase inhibitor GM6001 inhibited the production of CTF2. In zebrafish and nude mice, ARID1A silencing or CTF2 overexpression activated β-catenin signaling and promoted migration/invasion and metastasis of cancer cells in vivo. The inhibitors GM6001, BB94, and ICG-001 suppressed the migration and invasion of cancer cells with ARID1A-deficiency. Our findings provide novel insights into the mechanism of ARID1A metastasis and offer a scientific basis for targeted therapy of ARID1A-deficient cancer cells.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping